Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Antimicrobial resistance prevalence in patients receiving 14-day hybrid or 10-day concomitant therapy.
| Concomitant (n = 142) |
Hybrid (n = 139) |
p-Value | |
|---|---|---|---|
| Amoxicillin resistance | 0 | 0 | |
| Tetracycline resistance | 0 | 0 | |
| Clarithromycin resistance | 42 (29.6%) | 36 (25.9%) | 0.8 |
| Metronidazole resistance | 47 (33.1%) | 50 (36%) | 0.8 |
| Dual resistance | 18 (12.7%) | 15 (10.8%) | 0.7 |
| Levofloxacin resistance | 10 (7%) | 13 (9.3%) | 0.6 |
| Triple resistance | 0 | 0 |
